100 related articles for article (PubMed ID: 9070391)
1. Chronic amiodarone ingestion induces pulmonary toxicity in rats.
Carvalho CR; Kairalla RA; Capelozzi VL; Amato MB; Saldiva PH
Braz J Med Biol Res; 1996 Jun; 29(6):779-91. PubMed ID: 9070391
[TBL] [Abstract][Full Text] [Related]
2. Altered surfactant homeostasis and alveolar epithelial cell stress in amiodarone-induced lung fibrosis.
Mahavadi P; Henneke I; Ruppert C; Knudsen L; Venkatesan S; Liebisch G; Chambers RC; Ochs M; Schmitz G; Vancheri C; Seeger W; Korfei M; Guenther A
Toxicol Sci; 2014 Nov; 142(1):285-97. PubMed ID: 25163675
[TBL] [Abstract][Full Text] [Related]
3. Amiodarone-induced pulmonary fibrosis in Fischer 344 rats.
Reinhart PG; Lai YL; Gairola CG
Toxicology; 1996 Jun; 110(1-3):95-101. PubMed ID: 8658564
[TBL] [Abstract][Full Text] [Related]
4. A characterization of amiodarone-induced pulmonary toxicity in F344 rats and identification of surfactant protein-D as a potential biomarker for the development of the toxicity.
Taylor MD; Van Dyke K; Bowman LL; Miles PR; Hubbs AF; Mason RJ; Shannon K; Reasor MJ
Toxicol Appl Pharmacol; 2000 Sep; 167(3):182-90. PubMed ID: 10986009
[TBL] [Abstract][Full Text] [Related]
5. Coadministration of Atorvastatin and Amiodarone Increases the Risk of Pulmonary Fibrosis in Rats.
Nasri HR; Joukar S; Kheradmand H; Poursalehi HR; Dabiri S
Med Princ Pract; 2016; 25(2):150-4. PubMed ID: 26544718
[TBL] [Abstract][Full Text] [Related]
6. Amiodarone-induced pulmonary toxicity in Fischer rats: release of tumor necrosis factor alpha and transforming growth factor beta by pulmonary alveolar macrophages.
Reinhart PG; Gairola CG
J Toxicol Environ Health; 1997 Nov; 52(4):353-65. PubMed ID: 9354180
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of amiodarone-induced lung fibrosis but not alveolitis by angiotensin system antagonists.
Uhal BD; Wang R; Laukka J; Zhuang J; Soledad-Conrad V; Filippatos G
Pharmacol Toxicol; 2003 Feb; 92(2):81-7. PubMed ID: 12747577
[TBL] [Abstract][Full Text] [Related]
8. Effects of amiodarone-induced phospholipidosis on pulmonary host defense functions in rats.
Reasor MJ; McCloud CM; DiMatteo M; Schafer R; Ima A; Lemaire I
Proc Soc Exp Biol Med; 1996 Apr; 211(4):346-52. PubMed ID: 8618940
[TBL] [Abstract][Full Text] [Related]
9. Amiodarone induced phospholipidosis. Biochemical, morphological and functional changes in the lungs of rats chronically treated with amiodarone.
Riva E; Marchi S; Pesenti A; Bizzi A; Cini M; Veneroni E; Tavbani E; Boeri R; Bertani T; Latini R
Biochem Pharmacol; 1987 Oct; 36(19):3209-14. PubMed ID: 3663236
[TBL] [Abstract][Full Text] [Related]
10. The induction of pulmonary phospholipidosis and the inhibition of lysosomal phospholipases by amiodarone.
Heath MF; Costa-Jussà FR; Jacobs JM; Jacobson W
Br J Exp Pathol; 1985 Aug; 66(4):391-7. PubMed ID: 2992568
[TBL] [Abstract][Full Text] [Related]
11. Amiodarone-induced alveolar haemorrhage: a rare complication of a common medication.
Tanawuttiwat T; Harindhanavudhi T; Hanif S; Sahloul MZ
Heart Lung Circ; 2010 Jul; 19(7):435-7. PubMed ID: 20356785
[TBL] [Abstract][Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290
[TBL] [Abstract][Full Text] [Related]
13. Intratracheal amiodarone administration to F344 rats directly damages lung airway and parenchymal cells.
Taylor MD; Antonini JM; Roberts JR; Leonard SS; Shi X; Gannett PM; Hubbs AF; Reasor MJ
Toxicol Appl Pharmacol; 2003 Apr; 188(2):92-103. PubMed ID: 12691727
[TBL] [Abstract][Full Text] [Related]
14. The role of induced sputum in amiodarone-associated interstitial lung diseases.
Fireman E; Topilsky I; Viskin S; Priel IE
Cardiology; 2007; 108(4):223-7. PubMed ID: 17095870
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of pirfenidone on acute pulmonary injury and ensuing fibrosis in the hamster model of amiodarone-induced pulmonary toxicity.
Card JW; Racz WJ; Brien JF; Margolin SB; Massey TE
Toxicol Sci; 2003 Sep; 75(1):169-80. PubMed ID: 12832656
[TBL] [Abstract][Full Text] [Related]
16. Amiodarone lung toxicity: a human and experimental study.
Costa-Jussà FR; Corrin B; Jacobs JM
J Pathol; 1984 Oct; 144(2):73-9. PubMed ID: 6491834
[TBL] [Abstract][Full Text] [Related]
17. Influence of a pre-existing phospholipidosis on the accumulation of amiodarone and desethylamiodarone in rat alveolar macrophages.
Reasor MJ
Res Commun Chem Pathol Pharmacol; 1991 May; 72(2):169-81. PubMed ID: 1876748
[TBL] [Abstract][Full Text] [Related]
18. Amiodarone lung toxicity in a cardiac transplant candidate initially diagnosed by fine-needle aspiration: cytologic, histologic, and electronmicroscopic findings.
Omeroglu G; Kalugina Y; Ersahin C; Wojcik EM
Diagn Cytopathol; 2006 May; 34(5):351-4. PubMed ID: 16604561
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility to amiodarone-induced pulmonary toxicity: relationship to the uptake of amiodarone by isolated lung cells.
Wilson BD; Lippmann ML
Lung; 1996; 174(1):31-41. PubMed ID: 8747000
[TBL] [Abstract][Full Text] [Related]
20. [Drug-induced pulmonary interstitial disease].
Freise J; Wehmeier P; Welte T
Dtsch Med Wochenschr; 2010 Mar; 135(10):450-4. PubMed ID: 20198541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
